export const NSQHS_STANDARDS = {
  name: 'National Safety and Quality Health Service Standards',
  sector: 'healthcare',
  sourceType: 'standard',
  sourceUrl: 'https://www.safetyandquality.gov.au/standards/nsqhs-standards',
  version: '2021',
  effectiveDate: '2021-01-01',
  content: `
# National Safety and Quality Health Service (NSQHS) Standards

## Clinical Governance Standard

### Standard 1 - Clinical Governance
Leaders of a health service organisation have a responsibility to the community for continuous improvement of patient safety and quality of care.

#### Governance, Leadership and Culture
1.1 The governing body ensures the organisation's clinical governance framework supports safe and high-quality care.
1.2 The governing body sets priorities and strategic directions for safe and high-quality clinical care.
1.3 Health service leaders implement clinical governance systems to monitor and improve patient care.
1.4 Leaders support clinicians to understand and perform their delegated safety and quality roles.
1.5 The governing body monitors the action taken on quality improvement recommendations.

#### Quality Indicators for Clinical Governance
1.1.1 Clinical governance framework is documented and implemented
1.1.2 Roles and responsibilities for safety and quality are defined
1.1.3 Quality improvement systems are in place
1.1.4 Clinical performance data is collected and reviewed
1.1.5 Risk management processes address clinical risks

#### Patient Safety and Quality Systems
1.6 Patient safety and quality systems incorporate clinical incident management.
1.7 Actions are taken to minimise risks to patient safety identified from clinical incident data.
1.8 Actions are taken to improve clinical outcomes from quality improvement data.
1.9 Feedback is provided to consumers and the workforce about safety and quality performance.

#### Clinical Performance and Effectiveness
1.10 Evidence-based guidelines and pathways are used to inform clinical care.
1.11 Clinical variation is identified and actions are taken to reduce unwarranted variation.
1.12 Actions are taken to maximise the effectiveness of clinical care.

#### Safe Environment for Care
1.13 The environment promotes safe and high-quality care.
1.14 Workplace health and safety systems support safe clinical care.
1.15 Equipment is maintained and fit for purpose.

## Standard 2 - Partnering with Consumers

### Consumer Partnership
Healthcare organisations partner with consumers to plan, design, deliver and evaluate healthcare.

#### Healthcare Rights and Informed Consent
2.1 Consumers are informed of their healthcare rights.
2.2 Mechanisms are in place to support healthcare rights.
2.3 Informed consent processes comply with legislation and best practice.
2.4 Consumers are supported to make informed healthcare decisions.

#### Quality Indicators for Consumer Partnership
2.1.1 Consumer rights information is provided
2.1.2 Consent processes are documented
2.1.3 Consumers participate in care planning
2.1.4 Consumer feedback is collected and acted upon
2.1.5 Consumer representatives are involved in governance

#### Partnering with Consumers in Care
2.5 Consumers are partners in planning their own care.
2.6 Consumers are provided with information to support shared decision-making.
2.7 Care is provided that is respectful of individual differences.

#### Health Literacy
2.8 Health literacy needs of consumers are identified.
2.9 Communication is tailored to meet health literacy needs.
2.10 Written information is assessed for readability.

## Standard 3 - Preventing and Controlling Healthcare-Associated Infection

### Infection Prevention and Control Systems
3.1 An infection prevention and control program is implemented.
3.2 Surveillance systems monitor healthcare-associated infections.
3.3 Standard and transmission-based precautions are used.
3.4 Hand hygiene practices comply with national guidelines.

#### Quality Indicators for Infection Control
3.1.1 Infection control policies are current
3.1.2 Hand hygiene compliance is monitored
3.1.3 Healthcare-associated infection rates are tracked
3.1.4 Antimicrobial stewardship program is in place
3.1.5 Environmental cleaning standards are met

#### Reprocessing of Reusable Equipment
3.5 Reusable equipment is reprocessed according to standards.
3.6 Single-use items are not reused.
3.7 Sterilisation processes are monitored and validated.

#### Antimicrobial Stewardship
3.8 Antimicrobial stewardship program is implemented.
3.9 Antimicrobial use is reviewed and monitored.
3.10 Prescribers are supported to prescribe appropriately.

## Standard 4 - Medication Safety

### Systems for Medication Safety
4.1 Governance arrangements for medication safety are in place.
4.2 Medication management policies support safe prescribing.
4.3 High-risk medicines are identified and managed.
4.4 A medicines formulary is available to clinicians.

#### Quality Indicators for Medication Safety
4.1.1 Medication incidents are reported and analysed
4.1.2 High-risk medication protocols are implemented
4.1.3 Medication reconciliation is completed on admission
4.1.4 Clinical pharmacist review is available
4.1.5 Adverse drug reactions are documented

#### Clinical Medication Processes
4.5 Prescribing is in accordance with legislation and guidelines.
4.6 Medication review includes assessment of allergy status.
4.7 Medication reconciliation occurs at transitions of care.
4.8 Adverse drug reactions are recorded and reported.

#### Continuity of Medication Management
4.9 A best possible medication history is documented.
4.10 Current medicines list is provided at discharge.
4.11 Information about medicines is provided to patients.

## Standard 5 - Comprehensive Care

### Systems for Comprehensive Care
5.1 Systems support comprehensive care planning.
5.2 Processes for comprehensive care are implemented.
5.3 Comprehensive care plans address identified needs.

#### Quality Indicators for Comprehensive Care
5.1.1 Care plans are developed with consumers
5.1.2 Clinical assessments are completed
5.1.3 Risk screening is performed
5.1.4 Care is coordinated across providers
5.1.5 Discharge planning begins on admission

#### Developing the Comprehensive Care Plan
5.4 Assessment processes identify patient needs.
5.5 Risks and care needs are documented in the care plan.
5.6 Goals of care are established with patients.

#### Delivering Comprehensive Care
5.7 Actions are taken to meet care plan goals.
5.8 Progress towards goals is monitored.
5.9 Care is coordinated with other providers.

#### Minimising Patient Harm
5.10 Risks of falls are identified and managed.
5.11 Risks of pressure injuries are identified and managed.
5.12 Nutritional needs are identified and managed.
5.13 Cognitive impairment is identified and managed.
5.14 Risks associated with restricted mobility are managed.
5.15 Self-harm and suicide risks are identified and managed.

## Standard 6 - Communicating for Safety

### Clinical Communication Systems
6.1 Governance for clinical communication is established.
6.2 Processes support effective clinical communication.
6.3 Critical information is communicated at clinical handover.

#### Quality Indicators for Clinical Communication
6.1.1 Structured communication tools are used
6.1.2 Clinical handover procedures are followed
6.1.3 Critical results are communicated and acknowledged
6.1.4 Documentation standards are met
6.1.5 Identification processes are in place

#### Communication at Clinical Handover
6.4 Clinical handover processes are standardised.
6.5 Relevant patient information is transferred at handover.
6.6 Responsibility for patient care is clearly allocated.

#### Communication of Critical Information
6.7 Critical information is communicated in a timely manner.
6.8 Processes ensure critical results are acted upon.
6.9 Alerts and reminders support clinical decision-making.

#### Documentation
6.10 Clinical documentation is comprehensive and accurate.
6.11 Patient identification is confirmed at each encounter.
6.12 Documentation supports continuity of care.

## Standard 7 - Blood Management

### Blood Management Governance
7.1 Governance for blood management is established.
7.2 Systems support optimal blood management.
7.3 Blood and blood products are prescribed appropriately.

#### Quality Indicators for Blood Management
7.1.1 Patient blood management policy is implemented
7.1.2 Blood product use is monitored
7.1.3 Transfusion-related incidents are reported
7.1.4 Informed consent for transfusion is obtained
7.1.5 Alternatives to transfusion are considered

#### Prescribing and Clinical Use
7.4 Blood products are prescribed according to guidelines.
7.5 Informed consent is obtained before transfusion.
7.6 Patient identification is confirmed before transfusion.
7.7 Blood products are administered safely.

#### Managing Blood and Blood Products
7.8 Cold chain management meets requirements.
7.9 Blood product wastage is minimised.
7.10 Transfusion reactions are managed appropriately.

## Standard 8 - Recognising and Responding to Acute Deterioration

### Recognising and Responding to Deterioration
8.1 Governance for recognition and response systems is established.
8.2 Criteria for escalation of care are defined.
8.3 Systems enable recognition of acute deterioration.

#### Quality Indicators for Acute Deterioration
8.1.1 Early warning systems are implemented
8.1.2 Escalation protocols are followed
8.1.3 Rapid response team is available
8.1.4 Clinical review is timely
8.1.5 End-of-life care planning is documented

#### Detecting and Recognising Deterioration
8.4 Vital signs are monitored appropriately.
8.5 Early warning scores trigger appropriate responses.
8.6 Families can escalate concerns.

#### Escalation and Response
8.7 Escalation protocols are followed.
8.8 Rapid response systems are available.
8.9 Clinical review occurs in defined timeframes.

#### End-of-Life Care
8.10 Advance care planning is supported.
8.11 Goals of care are established and documented.
8.12 End-of-life care is provided with dignity.
`
}
